StockData
DHTIOTCServices-Help Supply ServicesFiscal year ends June 30

Dalrada Technology Group, Inc.

Financials through Q3 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 21, 2026
$0.01+0.01 (+82.50%)

Close on Oct 19, 2026

Market cap
$1.58M
P/E (TTM)
–
Dividend yield
–

Dalrada Technology Group, Inc. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Genefic [Member]$10.42M$13.22M$15.74M$13.62M–––51.3%-21.1%
Dalrada Energy [Member]$8.08M$2.80M$7.08M$1.26M–––39.8%+188.2%
Dalrada Technologies [Member]$1.35M$1.37M$2.05M$2.24M$1.19M––6.6%-1.8%
Dalrada Precision Manufacturing [Member]$448.41K$2.45M$4.87M$2.12M$481.31K––2.2%-81.7%
Corporate Segment [Member]$0$0$0$25.00K$18.82K$0–0.0%–
Engineering [Member]––––$977.26K$753.63K–––
Health [Member]––––$1.17M$407.07K–––
Inter Segment Eliminations [Member]––––-$1.07M-$606.75K–––
Information Technology [Member]––––$1.86M$624.20K–––
Education [Member]––––$452.25K$0–––
Dalrada Health [Member]–––$13.62M$1.74M––––
Dalrada Climate Technology [Member]–$2.80M$7.08M––––––
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019YoY
Dalrada Technologies [Member]-$62.00K-$235.10K$10.63K$30.18K-$276.39K––-73.6%
Dalrada Energy [Member]-$2.86M-$6.31M-$1.07M$967.64K–––-54.6%
Genefic [Member]-$3.62M-$6.61M-$5.78M$2.23M–––-45.3%
Dalrada Precision Manufacturing [Member]-$4.01M-$1.35M-$2.46M-$2.83M-$2.02M––+196.9%
Corporate Segment [Member]-$9.91M-$12.33M-$11.66M-$10.82M-$4.94M-$1.15M–-19.6%
Engineering [Member]––––-$1.30M-$794.40K––
Health [Member]––––-$1.22M$128.61K––
Inter Segment Eliminations [Member]––––-$742.99K-$751.98K––
Information Technology [Member]––––-$215.18K-$116.67K––
Education [Member]––––-$173.42K$0––
Dalrada Health [Member]–––$2.23M-$1.33M–––
Dalrada Climate Technology [Member]–-$6.31M-$1.07M–––––

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Unrelated Parties [Member]$18.62M$18.12M–––––91.7%+2.7%
Service Revenue Third Parties [Member]$11.89M$4.21M$20.13M$15.58M$2.02M$487.64K–58.6%+182.6%
Healthcare Insurers Government Payers And OTC Pharmaceutical Sales [Member]$8.43M$11.75M$12.55M––––41.5%-28.2%
Product Sales Third Parties [Member]$6.81M$13.92M$7.32M$2.28M$1.05M$466.95K$72.16K33.6%-51.1%
Related Parties [Member]$1.68M$1.72M–––––8.3%-2.2%
Service Revenue Related Party [Member]$1.60M$1.72M$2.21M$1.33M$270.05K$99.14K–7.9%-6.7%
Product Sales Related Party [Member]$0$140–––––0.0%-100.0%
Revenues [Member]–––$17.86M$3.07M$954.59K$72.16K––
Information technology and consulting services - related parties [Member]–––––$99.14K$0––
Product Sales Related Parties [Member]–$140$77.31K$75.32K$62.61K$124.43K$0––
Revenues Related Party [Member]–––$1.40M$332.66K$223.57K$0––
Information technology and consultingServices - third parties [Member]–––––$487.64K$0––
Healthcare Insurers [Member]–––$11.82M–––––
Healthcare Insurers And Government Payers [Member]––$12.55M$11.82M–––––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
United States$17.41M$17.19M$26.21M$16.54M$1.89M$591.37K$72.16K85.8%+1.3%
Spain$1.54M$310.57K$0––––7.6%+396.3%
India$970.05K$1.09M$1.64M$2.01M$1.19M$586.78K$04.8%-11.4%
United Kingdom$380.58K$1.24M$1.89M$725.44K$321.25K––1.9%-69.4%
Europe [Member]––––$331.25K$0–––

From the segment and revenue-disaggregation notes of Dalrada Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.